SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy

被引:20
|
作者
Ji, Jing [1 ]
Tao, Pengyu [2 ]
Wang, Qian [3 ]
Li, Lingxing [4 ]
Xu, Yuzhen [5 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Nephrol, Shanghai 200437, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Basic Med Sch, Shanghai 200120, Peoples R China
[3] Shandong First Med Univ & Shandong Acad Med Sci, Taian City Cent Hosp, Dept Cent Lab, Tai An, Shandong, Peoples R China
[4] Shandong First Med Univ & Shandong Acad Med Sci, Taian City Cent Hosp, Dept Cardiovasc Med, Tai An 271000, Shandong, Peoples R China
[5] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurol, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China
基金
美国国家科学基金会;
关键词
Diabetic nephropathy; SIRT1; inflammation; calorie restriction; acetylation; ESRD; CELLULAR SENESCENCE; THERAPEUTIC TARGET; INDUCED APOPTOSIS; OXIDATIVE STRESS; STEM-CELLS; RESVERATROL; PATHWAY; HYPOXIA; ACTIVATION; AUTOPHAGY;
D O I
10.2174/1871530320666201029143606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is referred to as the microvascular complication of the kidneys induced by insufficient production of insulin or an ineffective cellular response to insulin, and is the main cause of end-stage renal disease. Currently, available therapies provide only symptomatic relief and fail to improve the outcome of diabetic nephropathy. Studies on diabetic animals had shown overexpression of SIRT1 in both podocytes and renal tubular cells attenuated proteinuria and kidney injury in the animal model of DN. Sirt1 exerts renoprotective effects in DKD in part through the deacetylation of transcription factors involved in the disease pathogenesis, such as NF-kappa B, Smad3, FOXO and p53. The purpose of this review is to highlight the protective mechanism of SIRT1 involved in the pathogenesis of diabetic nephropathy.
引用
收藏
页码:835 / 842
页数:8
相关论文
共 50 条
  • [1] P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy
    Ma, Fuzhe
    Wu, Junduo
    Jiang, Ziping
    Huang, Wenlin
    Jia, Ye
    Sun, Weixia
    Wu, Hao
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2019, 1866 (08): : 1272 - 1281
  • [2] Protective Role of SIRT1 in Diabetic Vascular Dysfunction
    Orimo, Masayuki
    Minamino, Tohru
    Miyauchi, Hideyuki
    Tateno, Kaoru
    Okada, Sho
    Moriya, Junji
    Komuro, Issei
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) : 889 - U274
  • [3] Protective Effect of SIRT1 Activator on the Knee With Osteoarthritis
    Zhou, Zhenquan
    Deng, Zhenhan
    Liu, Yuwei
    Zheng, Yizi
    Yang, Shiwei
    Lu, Wei
    Xiao, Deming
    Zhu, Weimin
    [J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [4] Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy
    Hanan H. Ahmed
    Fatma M. Taha
    Heba S. Omar
    Heba M. Elwi
    Marwa Abdelnasser
    [J]. Molecular and Cellular Biochemistry, 2019, 457 : 1 - 9
  • [5] Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy
    Ahmed, Hanan H.
    Taha, Fatma M.
    Omar, Heba S.
    Elwi, Heba M.
    Abdelnasser, Marwa
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 457 (1-2) : 1 - 9
  • [6] Empagliflozin Ameliorates Kidney Injury in Diabetic Nephropathy via SIRT1 and TXNIP
    Liang, Riying
    Wang, Meijun
    Xu, Fen
    Cai, Mengyin
    [J]. DIABETES, 2020, 69
  • [7] The protective mechanism of SIRT1 on cartilage through regulation of LEF-1
    Hu, Xueyu
    Feng, Gangning
    Meng, Zhiqiang
    Ma, Long
    Jin, Qunhua
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [8] The protective mechanism of SIRT1 on cartilage through regulation of LEF-1
    Xueyu Hu
    Gangning Feng
    Zhiqiang Meng
    Long Ma
    Qunhua Jin
    [J]. BMC Musculoskeletal Disorders, 22
  • [9] Protective roles of SIRT1 in atherosclerosis
    Stein, Sokrates
    Matter, Christian M.
    [J]. CELL CYCLE, 2011, 10 (04) : 640 - 647
  • [10] Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury)
    Alireza Raji-amirhasani
    Mohammad Khaksari
    Fatemeh Darvishzadeh Mahani
    Zahra Hajializadeh
    [J]. Clinical and Experimental Nephrology, 2021, 25 : 807 - 821